In particular, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) have been reported to be elevated in the blood serum of patients diagnosed with advanced stage breast tumor and correlate with an increased number and size of metastatic sites [11], [12]. The gene discussed is IL6; the disease is breast neoplasm.